BLCM Bellicum Pharmaceuticals
WatchlistBellicum Pharmaceuticals News
America's Top Cancer Research Agency: Developing a Drug That Kills All Solid Cancers
Glonway, August 2 | America's top cancer treatment and research agency, the City of Hope (City of Hope) National Medical Center, issued an announcement on Tuesday saying that in pre-clinical research, scientists at the agency developed a targeted chemotherapy drug that can kill all solid malignant tumors (cancer). The preclinical research mentioned in the announcement has been published in the journal “Cytochemical Biology” in the form of a paper. The drug mentioned earlier (AOH1996) is an oral small molecule PCNA (proliferative cell nuclear antigen) inhibitor used to inhibit tumor cell proliferation.
12 Health Care Stocks Moving In Friday's Intraday Session
GainersMinerva Surgical (NASDAQ:UTRS) shares increased by 111.8% to $0.42 during Friday's regular session. As of 13:30 EST, Minerva Surgical's stock is trading at a volume of 85.0 million, which is 38
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersAridis Pharmaceuticals (NASDAQ:ARDS) shares increased by 98.9% to $0.37 during Wednesday's pre-market session. The market value of their outstanding shares is at $13.2 million. VistaGen Therape
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersBellicum Pharmaceuticals (NASDAQ:BLCM) stock rose 135.4% to $0.94 during Monday's pre-market session. The market value of their outstanding shares is at $8.5 million. Immuron (NASDAQ:IMRN) stoc
Changes in US stocks | Bellicum Pharmaceuticals surged 80% before the market, and Baker Bros Advisors held 19.99% of the shares
Glonghui, May 8 | Bellicum Pharmaceuticals (BLCM.US) surged 80% before the market to $0.72. According to the company's 13D filing, biomedical hedge fund Baker Bros Advisors holds 19.99% of the shares.
Bellicum Pharmaceuticals 13D Filing Shows Baker Bros. Advisors Report 19.99% Active Stake In Co.
Bellicum Pharmaceuticals 13D Filing Shows Baker Bros. Advisors Report 19.99% Active Stake In Co.
Short Interest in Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) Decreases By 15.8%
Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM – Get Rating) was the target of a significant decline in short interest in April. As of April 15th, there was short interest totalling 91,000 shares, a dec
12 Health Care Stocks Moving In Thursday's Intraday Session
GainersEvelo Biosciences (NASDAQ:EVLO) shares rose 138.7% to $0.24 during Thursday's regular session. Trading volume for this security as of 13:30 EST is 165.0 million, which is 44472.9% of its averag
Bellicum Pharmaceuticals (NASDAQ:BLCM) Now Covered by StockNews.com
StockNews.com began coverage on shares of Bellicum Pharmaceuticals (NASDAQ:BLCM – Get Rating) in a research report released on Saturday. The brokerage issued a sell rating on the biopharmaceutical com
12 Health Care Stocks Moving In Wednesday's Intraday Session
GainersVYNE Therapeutics (NASDAQ:VYNE) stock moved upwards by 38.0% to $4.32 during Wednesday's regular session. VYNE Therapeutics's stock is trading at a volume of 36.2 million shares as of 13:30 EST
Short Volatility Alert: Bellicum Pharma
On Monday, shares of Bellicum Pharma (NASDAQ:BLCM) experienced volatile short activity. After the activity, the stock price went up +102.85% to $0.57. The overall sentiment for BLCM has been Bearish
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersDermata Therapeutics (NASDAQ:DRMA) shares increased by 112.0% to $3.35 during Tuesday's pre-market session. The market value of their outstanding shares is at $2.8 million. Petros Pharma (NASDA
12 Health Care Stocks Moving In Monday's Intraday Session
GainersContraFect (NASDAQ:CFRX) stock rose 317.8% to $3.76 during Monday's regular session. As of 13:30 EST, this security is trading at a volume of 93.7 million shares, making up 12124.0% of its aver
Bellicum Pharmaceuticals (NASDAQ:BLCM) Stock Passes Below Fifty Day Moving Average of $0.73
Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM – Get Rating) shares passed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $0.73 and traded as low as
Bellicum Pharmaceuticals (NASDAQ:BLCM) Now Covered by Analysts at StockNews.com
StockNews.com began coverage on shares of Bellicum Pharmaceuticals (NASDAQ:BLCM – Get Rating) in a report issued on Wednesday morning. The firm issued a sell rating on the biopharmaceutical company's
Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) Short Interest Update
Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM – Get Rating) was the target of a large decrease in short interest during the month of March. As of March 15th, there was short interest totalling 64,500 sh
StockNews.com Begins Coverage on Bellicum Pharmaceuticals (NASDAQ:BLCM)
Analysts at StockNews.com started coverage on shares of Bellicum Pharmaceuticals (NASDAQ:BLCM – Get Rating) in a research report issued to clients and investors on Wednesday. The brokerage set a "sell
Bellicum Pharmaceuticals (NASDAQ:BLCM) Earns Sell Rating From Analysts at StockNews.com
StockNews.com started coverage on shares of Bellicum Pharmaceuticals (NASDAQ:BLCM – Get Rating) in a research report report published on Tuesday morning. The firm issued a sell rating on the biopharma
12 Health Care Stocks Moving In Friday's Intraday Session
GainerselectroCore (NASDAQ:ECOR) shares increased by 27.9% to $5.47 during Friday's regular session. As of 13:30 EST, electroCore's stock is trading at a volume of 91.3K, which is 434.3% of its averag
Stocks That Hit 52-Week Lows On Friday
On Friday, 469 companies hit new 52-week lows. Noteworthy Points From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was Bank of America (NYSE:BAC).TC BioPharm (Hol